Listed by the USPTO as INAM, SAHAR
Tech Center 1600 • Art Units: 1600 1622
This examiner grants 100% of resolved cases
INAM, SAHAR is a USPTO patent examiner in Tech Center 1600 and Art Unit 1600. The profile contains 2 resolved cases, and both cases are reflected in a 100.0% allowance rate. Median time to allowance is 986 days, while interview lift is 0.0%.
The listed companies are Antecip Bioventures Ii LLC, University of Florida Research Foundation Inc., and Ucl Business Ltd. The firms are Clark+Elbing LLP, K&L Gates LLP-Boston, and LEE & HAYES, P.C. Because the resolved-case base is limited, practitioners should treat the outcome figures as an initial reference rather than a broad measure of examination behavior.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18874975 | THIAZOLIDINEDIONES FOR THE TREATMENT OF MUSCULAR DYSTROPHIES | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 18726702 | RXR AGONISTS IN EYE DISORDERS | Non-Final OA | Baylor College of Medicine |
| 17909450 | Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene | Non-Final OA | Amicus Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy100.0% of resolved applications examined by Sahar Inam were allowed (2 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sahar Inam took 986 days on average from filing to allowance.
Sahar Inam examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
